‘Anti-aging freak’ makes $817 million as hot Japan stock triples in value
Online sales account for about 70% of total revenue for Premier Anti-Aging Co., which was poised to benefit as digitalization has started to disrupt the cosmetics industry.
Life expectancy hits record high again for Japanese men and women
Japanese women posted the highest life expectancy in the world, while Japanese men were in second place after Switzerland.
Eisai pushes second Alzheimer's drug despite call to probe U.S. approval of first
The U.S. Food and Drug Administration’s June approval of Aduhelm caused resignations among a panel of independent experts who said the therapy was ineffective.
A deserted Akita town offers a glimpse of Japan's demographic future
A lack of jobs is causing younger people to move away, which results in stores and other industries losing business and leaves mainly the retired population.
Number of dementia patients reported missing hits record-high 17,565 in 2020
Of the reported missing, 214 were not found by the end of the year, while 16,887 including those reported missing before 2020 were located, according to the police data.
Repeatedly dubbed the happiest nation on the planet with world-beating living standards, Finland should be deluged by people wanting to relocate, but in fact it faces an acute workforce shortage. "It's now widely acknowledged that we need a spectacular number of people to come to ...
Here we go again: China’s wrong turn in population policy
The cost of population aging are not a problem for China. It is a budgetary issue, not a demographic one.
Japan's older workers have fewer friends but more motivated to work than peers abroad
When asked whether they had close friends other than their family members, 31.3% of Japanese respondents said they did not, as the pandemic curtails social activities.
Nursing services in Japan juggling financial solvency and users' well-being
Should the government be turning to the private sector to provide care for the country's aging population?
U.S. FDA faces mounting criticism over Alzheimer's drug approval
The drug was authorized based on evidence that it can reduce brain plaques, a likely contributor to Alzheimer's, rather than proof that it slows progression of the disease.
China ages before it can become rich
One problem is that the Communist Party views people not as individual human beings but as tools to be manipulated to suit party policy at different times
Changing the game for Alzheimer's treatment, U.S. approves Eisai and Biogen's drug
The approval appears to signal a fundamental shift in the way the FDA thinks about Alzheimer's disease, which could have lasting ramifications for other drugs in the pipeline.
